Bal Pharma API (Active Pharmaceutical Ingredients) business began in 1996 with a simple objective of facilitating the manufacture of niche molecules which have been able to take the benefits of vertical integration to international and domestic markets.
The Bal Pharma’s API business has the competence and knowledge to undertake more than 30 different types of complex chemical reactions. Whether it is advance intermediates, fine chemicals or active pharmaceuticals ingredients, the company can seamlessly scale up from mg to MT quantities. It offers various activities
State of the art pilot and commercial scale multi purpose facilities
Pharmaceutical manufacturing plants conforming to GMP guidelines
R & D facilities to support early development of generic APIs
Patent non infringing processes
High quality documents – Drug master file
The API products are being exported to Japan, Australia, Spain, UK, Canada, Nigeria, Iceland, Slovenia, Romania, Argentina, Brazil, Pakistan, Germany, South Africa, Serbia, Taiwan, Malaysia, Thailand, Turkey, Egypt, Korea, Venezuela, Italy, Portugal, Morocco, Poland, Netherlands, Syria, Bangladesh, and Indonesia etc.
The range of APIs includes Anti Histamine, Platelet inhibitor, Antidiabetic, Anti Convulsant, urinary incontinence, Neuropathic pain, Anti allergy, Anti inflammatory, Diuretic, Acne Treatment etc
Bal Pharma’s successful operations in India, it made its presence in International markets more than a decade. Bal Pharma has its strong presence in various Non-Regulated, Semi-Regulated markets and now foraying into Regulated markets by opening its new manufacturing plant in Uttaranchal.
The International Division of Bal Pharma offer’s basket of products in various Therapeutic segments. Bal Pharma has its presence Sri Lanka, Malaysia, Singapore, Myanmar, Cambodia, Vietnam, Philippines, Iraq, Yemen, UAE, Zimbabwe, Malawi, Angola, Tanzania, Congo, Kenya, Somalia, Sudan, Cameroon, Nigeria, Liberia, Serria Leone, Mali, Costa-rica, Honduras, Panama and initiated in other Latin American markets which include Guatemala, Peru, Chile, Venezuela.
International
